Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neurology · Familial Focal Epilepsy with Variable Foci 1

The Biology of FFEVF1: The Two-Hit Theory

At a Glance

FFEVF1 is most often linked to a DEPDC5 gene change that can make brain cells overly active. A proposed second change in one developing brain cell may create a seizure-producing area, but the change can be too small to appear on MRI and seizure locations can differ within a family.

Understanding the biology of Familial Focal Epilepsy with Variable Foci 1 (FFEVF1) requires looking deep into the cells of the brain. While the name is complex, the underlying cause is a specific genetic “instruction manual” that isn’t working quite right.

The DEPDC5 Gene and the GATOR1 Complex

Most cases of FFEVF1 are caused by a mutation in the DEPDC5 gene [1]. To understand what this gene does, imagine a high-performance car. The car has an engine that drives growth and activity, called the mTOR pathway [2]. If the mTOR engine runs too fast, brain cells grow too large and become “electrically noisy,” leading to seizures [3][4].

The DEPDC5 protein doesn’t work alone. It joins two other proteins (NPRL2 and NPRL3) to form a team called the GATOR1 complex [5]. This complex is the “brake” on the mTOR engine [2].

  • Normal GATOR1: Keeps the mTOR engine at a safe, controlled speed.
  • Mutated DEPDC5: The brake is weakened or missing. The mTOR engine begins to “rev” out of control (mTOR hyperactivation), causing the brain cells to behave abnormally [6][4].

The Two-Hit Theory: Why Families Differ

One of the most confusing parts of FFEVF1 is why one person has a visible brain abnormality while their relative with the same gene does not. Scientists often explain this using the Two-Hit Hypothesis, which is a proposed mechanism for some cases [7].

  • The First Hit (Inherited): A child is born with one mutated copy of the DEPDC5 gene in every cell of their body. They inherited this from a parent or it started new with them. However, they still have a second, healthy copy of the gene acting as a backup brake [8].
  • The Second Hit (Spontaneous): During brain development in the womb, a single cell in the baby’s growing brain might experience a random, spontaneous mutation in that second “backup” copy of DEPDC5. This is the “second hit” [7][9].

In the small patch of brain cells where both “brakes” are affected, the mTOR engine may become hyperactive. These cells can grow into a localized area of abnormal tissue called Focal Cortical Dysplasia (FCD) [10][11].

What is Known vs. Still Being Studied

The second hit is a matter of chance. This helps explain the “variable” nature of the condition, though it is not a settled rule for every single case:

  • If a second hit occurs: The person may develop a visible FCD on an MRI. This patch of tissue often becomes the “focus” where their seizures start [7][10].
  • If no second hit occurs: The person still has their backup copy of the gene working in all their brain cells. They might have a completely normal-looking brain on an MRI [8]. They may still have seizures because even one altered brake makes the brain more sensitive [6].
  • Different Locations: Because the second hit happens randomly, it can occur in the frontal lobe of one person and the temporal lobe of another. This is one proposed reason why the seizure focus varies even among siblings [7][12].

Is FCD Always Visible?

It is important to know that approximately 28% of people with DEPDC5 mutations show a malformation like FCD on an MRI [13]. However, some “second hits” involve such a small number of cells that they are invisible to current MRI scanners [14]. In these cases, the brain may look normal, but the underlying “two-hit” biology may still be driving the seizures [9]. Seizure networks remain complex and are still being studied, so having a nonlesional MRI doesn’t prove there isn’t a second hit, nor does every person with epilepsy definitely have one [13].

Common questions in this guide

What is FFEVF1, and what gene is usually involved?
FFEVF1 is a genetic form of focal epilepsy in which the seizure starting area can vary between relatives. Most cases are linked to a change in the DEPDC5 gene, which normally helps a protein team called GATOR1 limit growth and activity signals in brain cells.
What does the two-hit theory mean in FFEVF1?
A person may be born with one altered copy of DEPDC5 in every cell, while the other copy still works. The theory proposes that a second, spontaneous change in one developing brain cell can disable the backup copy in a small area, but this explanation does not apply to every case.
Can FFEVF1 cause focal cortical dysplasia?
Yes, a second DEPDC5 change in a small group of brain cells may lead to focal cortical dysplasia, a localized area of abnormal brain tissue. This area can become the starting point for seizures, although not everyone with FFEVF1 has visible dysplasia.
Can my MRI be normal if I have a DEPDC5 mutation and seizures?
Yes. A brain MRI may look normal when the affected group of cells is too small for current scanners to detect, or when no visible focal abnormality develops. A normal MRI does not prove that no microscopic change exists, and it does not mean every person has a second mutation.
Why can relatives with FFEVF1 have different seizure locations?
The proposed second change can happen by chance in different parts of the developing brain, such as the frontal lobe in one person and the temporal lobe in another. This may help explain why seizure starting areas vary among relatives, even when they share a DEPDC5 mutation.
Can brain tissue removed during epilepsy surgery be tested for a second DEPDC5 change?
If epilepsy surgery is medically needed, resected tissue may be studied for somatic, or cell-specific, genetic changes. Whether testing is available and useful depends on the clinical team, laboratory, and research options, so ask your neurologist or epilepsy surgeon.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my child have a pathogenic DEPDC5 variant, and how does that relate to the mTOR pathway?
  2. 2.How does the 'two-hit theory' influence whether we should look for a structural abnormality on an MRI?
  3. 3.Are there current research studies investigating how seizure networks develop in nonlesional FFEVF1 cases?
  4. 4.If surgery were ever necessary, could the resected tissue be tested for somatic mutations to help us understand the cause?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Clinical and genetic features of GATOR1 complex-associated epilepsy.

    Yin K, Lei X, Yan Z, et al.

    Journal of medical genetics 2023; (60(8)):784-790 doi:10.1136/jmg-2021-108364.

    PMID: 36604176
  2. 2

    Skeletal muscle-specific knockout of DEP domain containing 5 protein increases mTORC1 signaling, muscle cell hypertrophy, and mitochondrial respiration.

    Graber TG, Fry CS, Brightwell CR, et al.

    The Journal of biological chemistry 2019; (294(11)):4091-4102 doi:10.1074/jbc.RA118.005970.

    PMID: 30635399
  3. 3

    DEPDC5 and NPRL3 modulate cell size, filopodial outgrowth, and localization of mTOR in neural progenitor cells and neurons.

    Iffland PH, Baybis M, Barnes AE, et al.

    Neurobiology of disease 2018; (114()):184-193 doi:10.1016/j.nbd.2018.02.013.

    PMID: 29481864
  4. 4

    Acute knockdown of Depdc5 leads to synaptic defects in mTOR-related epileptogenesis.

    De Fusco A, Cerullo MS, Marte A, et al.

    Neurobiology of disease 2020; (139()):104822 doi:10.1016/j.nbd.2020.104822.

    PMID: 32113911
  5. 5

    Architecture of the human GATOR1 and GATOR1-Rag GTPases complexes.

    Shen K, Huang RK, Brignole EJ, et al.

    Nature 2018; (556(7699)):64-69 doi:10.1038/nature26158.

    PMID: 29590090
  6. 6

    DEPDC5 haploinsufficiency drives increased mTORC1 signaling and abnormal morphology in human iPSC-derived cortical neurons.

    Klofas LK, Short BP, Snow JP, et al.

    Neurobiology of disease 2020; (143()):104975 doi:10.1016/j.nbd.2020.104975.

    PMID: 32574724
  7. 7

    Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy.

    Ribierre T, Deleuze C, Bacq A, et al.

    The Journal of clinical investigation 2018; (128(6)):2452-2458.

    PMID: 29708508
  8. 8

    Clinical Course May Be Independent from Neuroimaging in DEPDC-5-Related Epilepsy.

    Bartolini E, Della Vecchia S, Biagioni T, et al.

    Neuropediatrics 2023; (54(5)):347-350 doi:10.1055/a-2067-5096.

    PMID: 37003255
  9. 9

    Identification of a Second-Hit Brain Somatic DEPDC5 Variant Supports Causality of a DEPDC5 Germline Variant of Uncertain Significance. Time for a Classification Update?

    Alsayed A, Hakim Z, Merrikh D, et al.

    American journal of medical genetics. Part A 2025; (197(12)):e64204 doi:10.1002/ajmg.a.64204.

    PMID: 40742146
  10. 10

    Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA.

    Lee WS, Stephenson SEM, Howell KB, et al.

    Annals of clinical and translational neurology 2019; (6(7)):1338-1344 doi:10.1002/acn3.50815.

    PMID: 31353856
  11. 11

    Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.

    Baldassari S, Ribierre T, Marsan E, et al.

    Acta neuropathologica 2019; (138(6)):885-900 doi:10.1007/s00401-019-02061-5.

    PMID: 31444548
  12. 12

    Magnetoencephalogram-assisted diagnosis of familial focal epilepsy with variable foci in a Chinese family with a novel DEPDC5 mutation.

    Li M, Huang Z, Zhang X, et al.

    Epileptic disorders : international epilepsy journal with videotape 2019; (21(3)):289-294 doi:10.1684/epd.2019.1066.

    PMID: 31225799
  13. 13

    Insights Into DEPDC5-Related Epilepsy From 586 People: Variant Penetrance, Phenotypic Spectrum, and Treatment Outcomes.

    Ochoa-Urrea M, Butler EA, Bruenger T, et al.

    Neurology 2025; (105(9)):e214235 doi:10.1212/WNL.0000000000214235.

    PMID: 41118617
  14. 14

    Somatic variant analysis of resected brain tissue in epilepsy surgery patients.

    Sanders MWCB, Koeleman BPC, Brilstra EH, et al.

    Epilepsia 2024; (65(12)):e209-e215 doi:10.1111/epi.18148.

    PMID: 39460693

This page explains the proposed DEPDC5 two-hit mechanism in FFEVF1 for educational purposes and does not constitute medical advice or a diagnosis. A neurologist or genetics professional should interpret your genetic testing and MRI findings.

Get notified when new evidence is published on Epilepsy, familial focal, with variable foci 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.